Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Worried About a Correction? Buy These 2 Evergreen Dividend Stocks
02:30pm, Wednesday, 11'th May 2022 The Motley Fool
Their businesses are rock-solid, and so are their dividend payments.
This 1 Thing Could Make Novavax a Vaccine Leader
10:30am, Wednesday, 11'th May 2022 The Motley Fool
It's all about the coronavirus market of the future.
2 Cash-Rich Dividend Stocks To Counter Growing U.S. Recession Risks
05:48am, Wednesday, 11'th May 2022 Investing.com
Dow books fourth straight day of losses as stocks end mixed
08:48pm, Tuesday, 10'th May 2022 MarketWatch
Major U.S. stock benchmarks end mixed Tuesday, with the Dow Jones Industrial Average booking a fourth straight day of losses, on the eve of a key inflation reading.
Why Biohaven Pharmaceutical Stock Soared Today
08:42pm, Tuesday, 10'th May 2022 The Motley Fool
An industry titan wants to buy the biotech for a whopping $11.6 billion.
Novavax (NVAX) Down on Q1 Earnings and Sales Lagging Estimates
06:47pm, Tuesday, 10'th May 2022 Zacks Investment Research
Novavax (NVAX) misses on both earnings and sales for the first quarter of 2022. Its shares decline in after-hours trading following the result announcement.
2 Extraordinary Events Sent These 2 Stocks Soaring Tuesday
06:15pm, Tuesday, 10'th May 2022 The Motley Fool
Find out how the rest of the markets are behaving.
What is Paxlovid, Pfizer’s COVID antiviral drug, and how effective is it?
05:50pm, Tuesday, 10'th May 2022 MarketWatch
The latest on Paxlovid, its availability, side effects and relapses. The pill can decrease hospitalization or death from COVID-19 in high-risk adults by 89%.
Despite Positive Signs, Moderna Not A Sure Bet In Post-Pandemic Era
05:04pm, Tuesday, 10'th May 2022 Investing.com
Here's a list of 50 companies that are well-armed to beat back inflation
01:27pm, Tuesday, 10'th May 2022 MarketWatch
Our call of the day offers an update on what's been a popular strategy in recent months --- picking companies with pricing power.
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
01:23pm, Tuesday, 10'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Acquires Biohaven For $11B
Pfizer Inc (NYSE: PFE) will acquire Biohaven Pharmaceutical Hold
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
01:00pm, Tuesday, 10'th May 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
New York Gov. Hochul tests positive for COVID, as two omicron subvariants spread across Empire State
11:47am, Tuesday, 10'th May 2022 MarketWatch
New York Gov. Kathy Hochul tested positive for COVID-19 on Sunday, becoming the latest political leader to succumb to the virus, which is rising across the state driven by two subvariants of omicron.
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
11:00am, Tuesday, 10'th May 2022 Benzinga
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report. What would have been a trophy quarter to flaunt, given COVID-19 revenue only just
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
10:20am, Tuesday, 10'th May 2022 Zacks Investment Research
Sector ETF report for IHE
